|
1
|
Khan IS and Ehtesham M: Emerging
strategies for the treatment of tumor stem cells in central nervous
system malignancies. Adv Exp Med Biol. 853:167–187. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chien LN, Ostrom QT, Gittleman H, Lin JW,
Sloan AE, Barnett GH, Elder JB, McPherson C, Warnick R, Chiang YH,
et al: International differences in treatment and clinical outcomes
for high grade glioma. PLoS One. 10:e01296022015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mannas JP, Lightner DD, Defrates SR,
Pittman T and Villano JL: Long-term treatment with temozolomide in
malignant glioma. J Clin Neurosci. 21:121–123. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Perry A and Wesseling P: Histologic
classification of gliomas. Handb Clin Neurol. 134:71–95. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reulen HJ, Poepperl G, Goetz C, Gildehaus
FJ, Schmidt M, Tatsch K, Pietsch T, Kraus T and Rachinger W:
Long-term outcome of patients with WHO Grade III and IV gliomas
treated by fractionated intracavitary radioimmunotherapy. J
Neurosurg. 123:760–770. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Modrek AS, Bayin NS and Placantonakis DG:
Brain stem cells as the cell of origin in glioma. World J Stem
Cells. 6:43–52. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dietrich J, Diamond EL and Kesari S:
Glioma stem cell signaling: Therapeutic opportunities and
challenges. Expert Rev Anticancer Ther. 10:709–722. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qi P and Du X: The long non-coding RNAs, a
new cancer diagnostic and therapeutic gold mine. Mod Pathol.
26:155–165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li X, Wu Z, Fu X and Han W: Long noncoding
RNAs: Insights from biological features and functions to diseases.
Med Res Rev. 33:517–553. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen X, Kong J, Ma Z, Gao S and Feng X: Up
regulation of the long non-coding RNA NEAT1 promotes esophageal
squamous cell carcinoma cell progression and correlates with poor
prognosis. Am J Cancer Res. 5:2808–2815. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Li Y, Chen W, He F, Tan Z, Zheng J,
Wang W, Zhao Q and Li J: NEAT expression is associated with tumor
recurrence and unfavorable prognosis in colorectal cancer.
Oncotarget. 6:27641–27650. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He C, Jiang B, Ma J and Li Q: Aberrant
NEAT1 expression is associated with clinical outcome in high grade
glioma patients. APMIS. 124:169–174. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chakravarty D, Sboner A, Nair SS,
Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K,
Kossai M, et al: The oestrogen receptor alpha-regulated lncRNA
NEAT1 is a critical modulator of prostate cancer. Nat Commun.
5:53832014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Blume CJ, Hotz-Wagenblatt A, Hüllein J,
Sellner L, Jethwa A, Stolz T, Slabicki M, Lee K, Sharathchandra A,
Benner A, et al: p53-dependent non-coding RNA networks in chronic
lymphocytic leukemia. Leukemia. 29:2015–2023. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang P, Wu T, Zhou H, Jin Q, He G, Yu H,
Xuan L, Wang X, Tian L, Sun Y, et al: Long noncoding RNA NEAT1
promotes laryngeal squamous cell cancer through regulating
miR-107/CDK6 pathway. J Exp Clin Cancer Res. 35:222016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Q, Sun S, Yu W, Jiang J, Zhuo F, Qiu
G, Xu S and Jiang X: Altered expression of long non-coding RNAs
during genotoxic stress-induced cell death in human glioma cells. J
Neurooncol. 122:283–292. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang X, Ma Z, Xiao Z, Liu H, Dou Z and Shi
H Fengxand: Chk1 knockdown confers radiosensitization in prostate
cancer stem cells. Oncol Rep. 28:2247–2254. 2012.PubMed/NCBI
|
|
18
|
Chen W, Xiao Z, Zhao Y, Huang L and Du G:
HIF-1α inhibition sensitizes pituitary adenoma cells to
temozolomide by regulating MGMT expression. Oncol Rep.
30:2495–2501. 2013.PubMed/NCBI
|
|
19
|
Lathia JD, Hitomi M, Gallagher J, Gadani
SP, Adkins J, Vasanji A, Liu L, Eyler CE, Heddleston JM, Wu Q, et
al: Distribution of CD133 reveals glioma stem cells self-renew
through symmetric and asymmetric cell divisions. Cell Death Dis.
2:e2002011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dahlrot RH, Hansen S, Jensen SS, Schrøder
HD, Hjelmborg J and Kristensen BW: Clinical value of CD133 and
nestin in patients with glioma: A population-based study. Int J
Clin Exp Pathol. 7:3739–3751. 2014.PubMed/NCBI
|
|
21
|
Clément V, Dutoit V, Marino D, Dietrich PY
and Radovanovic I: Limits of CD133 as a marker of glioma
self-renewing cells. Int J Cancer. 125:244–248. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Griguer CE, Oliva CR, Gobin E, Marcorelles
P, Benos DJ, Lancaster JR Jr and Gillespie GY: CD133 is a marker of
bioenergetic stress in human glioma. PLoS One. 3:e36552008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu J, Lai G, Wan F, Xiao Z, Zeng L, Wang
X, Ye F and Lei T: Knockdown of checkpoint kinase 1 is associated
with the increased radiosensitivity of glioblastoma stem-like
cells. Tohoku J Exp Med. 226:267–274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhen L, Yun-Hui L, Hong-Yu D, Jun M and
Yi-Long Y: Long noncoding RNA NEAT1 promotes glioma pathogenesis by
regulating miR-449b-5p/c-Met axis. Tumour Biol. 37:673–683. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rader J, Russell MR, Hart LS, Nakazawa MS,
Belcastro LT, Martinez D, Li Y, Carpenter EL, Attiyeh EF, Diskin
SJ, et al: Dual CDK4/CDK6 inhibition induces cell-cycle arrest and
senescence in neuroblastoma. Clin Cancer Res. 19:6173–6182. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brzozowska A, Toruń A and Mazurkiewicz M:
The impact of surgery on the efficacy of adjuvant therapy in
glioblastoma multiforme. Adv Clin Exp Med. 24:279–287. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jung J, Gilbert MR and Park DM: Isolation
and propagation of glioma stem cells from acutely resected tumors.
Methods Mol Biol. 1516:361–369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Codrici E, Enciu AM, Popescu ID, Mihai S
and Tanase C: Glioma stem cells and their microenvironments:
Providers of challenging therapeutic targets. Stem Cells Int.
2016:57284382016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liebelt BD, Shingu T, Zhou X, Ren J, Shin
SA and Hu J: Glioma stem cells: Signaling, microenvironment, and
therapy. Stem Cells Int. 2016:78498902016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim SS, Pirollo KF and Chang EH: Isolation
and culturing of glioma cancer stem cells. Curr Protoc Cell Biol.
67:23.10.1–23.10.10. 2015.doi: 10.1002/0471143030.cb2310s67.
View Article : Google Scholar
|
|
31
|
Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu
S, Zhang A, Jia Z, Wang G, Yu S, et al: LncRNA profile of
glioblastoma reveals the potential role of lncRNAs in contributing
to glioblastoma pathogenesis. Int J Oncol. 40:2004–2012.
2012.PubMed/NCBI
|
|
32
|
Sørensen KP, Thomassen M, Tan Q, Bak M,
Cold S, Burton M, Larsen MJ and Kruse TA: Long non-coding RNA
expression profiles predict metastasis in lymph node-negative
breast cancer independently of traditional prognostic markers.
Breast Cancer Res. 17:552015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang X, Sun S, Pu JK, Tsang AC, Lee D,
Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA
expression profiles predict clinical phenotypes in glioma.
Neurobiol Dis. 48:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li R, Qian J, Wang YY, Zhang JX and You
YP: Long noncoding RNA profiles reveal three molecular subtypes in
glioma. CNS Neurosci Ther. 20:339–343. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Clemson CM, Hutchinson JN, Sara SA,
Ensminger AW, Fox AH, Chess A and Lawrence JB: An architectural
role for a nuclear noncoding RNA: NEAT1 RNA is essential for the
structure of paraspeckles. Mol Cell. 33:717–726. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Choudhry H, Albukhari A, Morotti M, Haider
S, Moralli D, Smythies J, Schödel J, Green CM, Camps C, Buffa F, et
al: Tumor hypoxia induces nuclear paraspeckle formation through
HIF-2α dependent transcriptional activation of NEAT1 leading to
cancer cell survival. Oncogene. 34:45462015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
You J, Zhang Y, Liu B, Li Y, Fang N, Zu L,
Li X and Zhou Q: MicroRNA-449a inhibits cell growth in lung cancer
and regulates long noncoding RNA nuclear enriched abundant
transcript 1. Indian J Cancer. 51:(Suppl 3). e77–e81. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Campos B and Herold-Mende CC: Insight into
the complex regulation of CD133 in glioma. Int J Cancer.
128:501–510. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang M, Song T, Yang L, Chen R, Wu L,
Yang Z and Fang J: Nestin and CD133: Valuable stem cell-specific
markers for determining clinical outcome of glioma patients. J Exp
Clin Cancer Res. 27:852008. View Article : Google Scholar : PubMed/NCBI
|
